BLUE - Bluebird bio Inc
IEX Last Trade
0.5624
-0.030 -5.334%
Share volume: 10,443,497
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.59
-0.03
-5.06%
Fundamental analysis
7%
Profitability
0%
Dept financing
14%
Liquidity
47%
Performance
1%
Performance
5 Days
-18.47%
1 Month
-50.31%
3 Months
-37.30%
6 Months
-66.58%
1 Year
-84.99%
2 Year
-90.23%
Key data
Stock price
$0.56
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.56 - $5.53
52 WEEK CHANGE
-$0.86
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO:
Region: US
Website: bluebirdbio.com
Employees: 733
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: bluebirdbio.com
Employees: 733
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
we are leading the gene therapy revolution. our integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing – providing us with the potential to treat, and hopefully cure, a broad range of serious diseases. we have a lot of energy, and it’s not just the abundance of coffee that keeps us going. find out what sparks our excitement and inspires us every day.
Recent news